Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection

Immunology

Volumn 124, Issue 2, 2008, Pages 175-185

  Agger, Else Marie ^a   Cassidy, Joseph P ^b   Brady, Joseph ^b   Korsholm, Karen S ^a   Vingsbo Lundberg, Carina ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Lung immunology disease; Mycobacterium tuberculosis; T cells; Vaccines

Indexed keywords

AG85B ESAT 6 SUBUNIT VACCINE; ALUMINUM; ALUMINUM HYDROXIDE; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 17; INTERLEUKIN 5; LIPOSOME; NITRIC OXIDE SYNTHASE; PHOSPHORYL LIPID A; SUBUNIT VACCINE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; DRUG EFFICACY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOMA; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; LUNG GRANULOMA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; FEMALE; GRANULOMA; IMMUNIZATION; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; VACCINES, SUBUNIT;

EID: 43749108819     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02751.x     Document Type: Article

References (45)

1. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993 178 : 2243 7.
2. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993 178 : 2249 54.
3. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996 335 : 1956 61.
4. Remiszewski P, Roszkowska SLB, Winek J et al. Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 2006 73 : 375 8.
5. Andersen P, Doherty TM. TB subunit vaccines - putting the pieces together. Microbes Infect 2005 7 : 911 21.
6. Skeiky YA, Alderson MR, Ovendale PJ et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol 2004 172 : 7618 28.
7. Gilbert SC, Moorthy VS, Andrews L et al. Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 2006 24 : 4554 61.
8. Doherty TM, Olsen AW, Weischenfeldt J et al. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 2004 190 : 2146 53.
9. McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004 10 : 1240 4.
10. Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun 1997 65 : 623 9.
11. Sacco R, Hagen M, Sandor M, Weinstock JV, Lynch RG. Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol 2002 104 : 274 81.
12. Ordway DJ, Costa L, Martins M, Silveira H, Amaral L, Arroz MJ, Ventura FA, Dockrell HM. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis 2004 190 : 756 66.
13. Sugawara I, Yamada H, Mizuno S, Iwakura Y. IL-4 is required for defense against mycobacterial infection. Microbiol Immunol 2000 44 : 971 9.
14. Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001 194 : 1847 59.
15. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003 3 : 23 35.
16. Olsen AW, van Pinxteren LA, Okkels LM, Rasmussen PB, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001 69 : 2773 8.
17. Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996 157 : 3527 33.
18. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991 59 : 1558 63.
19. Rosenkrands I, Agger EM, Olsen AW, Korsholm KS, Andersen CS, Jensen KT, Andersen P. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect Immun 2005 73 : 5817 26.
20. Agger EM, Rosenkrands I, Olsen AW et al. Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. Vaccine 2006 24 : 5452 60.
21. Theisen M, Soe S, Brunstedt K, Follmann F, Bredmose L, Israelsen H, Madsen SM, Druilhe P. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Vaccine 2004 22 : 1188 98.
22. Martin RM, Lew AM. Is IgG2a a good Th1 marker in mice. Immunol Today 1998 19 : 49.
23. Charles PC, Weber KS, Cipriani B, Brosnan CF. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J Neuroimmunol 1999 100 : 64 73.
24. D'Souza S, Rosseels V, Romano M et al. Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun 2003 71 : 483 93.
25. Doherty TM, Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet 2006 367 : 947 9.
26. Demissie A, Abebe M, Aseffa A et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 2004 172 : 6938 43.
27. Elliott AM, Hodsdon WS, Kyosiimire J et al. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg 2004 98 : 660 70.
28. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007 8 : 369 77.
29. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995 16 : 34 8.
30. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001 2 : 415 22.
31. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002 2 : 251 62.
32. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998 32 : 155 72.
33. Austrup F, Vestweber D, Borges E et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997 385 : 81 3.
34. Iezzi G, Scheidegger D, Lanzavecchia A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med 2001 193 : 987 93.
35. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001 108 : 1331 9.
36. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998 19 : 568 74.
37. Stephens R, Randolph DA, Huang G, Holtzman MJ, Chaplin DD. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol 2002 169 : 5458 67.
38. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 13 : 715 25.
39. Ordway D, Harton M, Henao-Tamayo M, Montoya R, Orme IM, Gonzalez-Juarrero M. Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis. J Immunol 2006 176 : 4931 9.
40. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995 154 : 3359 72.
41. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997 94 : 5243 8.
42. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001 193 : 271 80.
43. Ratcliffe HL, Palladino VS. Tuberculosis induced by droplet nuclei infection; initial homogeneous response of small mammals (rats, mice, guinea pigs, and hamsters) to human and to bovine bacilli, and the rate and pattern of tubercle development. J Exp Med 1953 97 : 61 8.
44. Turner OC, Basaraba RJ, Orme IM. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect Immun 2003 71 : 864 71.
45. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997 78 : 57 66.